JPMorgan Chase & Co. Acquires 344,875 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

JPMorgan Chase & Co. raised its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 29.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,511,403 shares of the company's stock after buying an additional 344,875 shares during the quarter. JPMorgan Chase & Co. owned 0.89% of Option Care Health worth $35,065,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of the stock. Janus Henderson Group PLC raised its holdings in Option Care Health by 4.1% during the 3rd quarter. Janus Henderson Group PLC now owns 214,081 shares of the company's stock worth $6,699,000 after buying an additional 8,467 shares during the period. State Street Corp increased its position in shares of Option Care Health by 1.4% during the third quarter. State Street Corp now owns 6,257,172 shares of the company's stock worth $195,849,000 after acquiring an additional 83,395 shares in the last quarter. Wolverine Trading LLC acquired a new stake in shares of Option Care Health during the third quarter worth $222,000. Zacks Investment Management raised its holdings in shares of Option Care Health by 7.4% during the third quarter. Zacks Investment Management now owns 60,578 shares of the company's stock worth $1,896,000 after acquiring an additional 4,168 shares during the period. Finally, Orion Portfolio Solutions LLC boosted its stake in Option Care Health by 2.3% in the 3rd quarter. Orion Portfolio Solutions LLC now owns 28,232 shares of the company's stock worth $884,000 after purchasing an additional 636 shares during the period. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Analysts Set New Price Targets

A number of research firms have issued reports on OPCH. JPMorgan Chase & Co. increased their target price on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. JMP Securities reissued a "market outperform" rating and issued a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and upped their price target for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and lifted their price objective for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. Finally, Barrington Research increased their target price on shares of Option Care Health from $33.00 to $38.00 and gave the stock an "outperform" rating in a report on Thursday, February 27th. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $33.00.

Option Care Health Stock Down 6.4 %

Shares of NASDAQ:OPCH traded down $2.14 during midday trading on Friday, hitting $31.55. The stock had a trading volume of 5,341,789 shares, compared to its average volume of 1,774,881. The company has a market cap of $5.18 billion, a P/E ratio of 26.51, a PEG ratio of 2.30 and a beta of 1.07. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The business's 50-day simple moving average is $33.24 and its 200-day simple moving average is $28.60. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77.

Insider Buying and Selling at Option Care Health

In other news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares in the company, valued at $1,495,835.24. The trade was a 40.80 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.64% of the company's stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.